Business Description
ORIC Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US68622P1093
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 75.65 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.03 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 1.1 | |||||
3-Year EPS without NRI Growth Rate | 4.2 | |||||
3-Year FCF Growth Rate | 7 | |||||
3-Year Book Growth Rate | -19.7 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 64.63 | |||||
9-Day RSI | 53.3 | |||||
14-Day RSI | 46.36 | |||||
6-1 Month Momentum % | 60.15 | |||||
12-1 Month Momentum % | 114.68 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 10.39 | |||||
Quick Ratio | 10.39 | |||||
Cash Ratio | 10.18 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.4 | |||||
Shareholder Yield % | -0.04 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -43.2 | |||||
ROA % | -38.97 | |||||
ROIC % | -262.45 | |||||
ROC (Joel Greenblatt) % | -3564.58 | |||||
ROCE % | -45.86 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.39 | |||||
Price-to-Tangible-Book | 2.39 | |||||
EV-to-EBIT | -4.01 | |||||
EV-to-EBITDA | -4.04 | |||||
EV-to-FCF | -4.93 | |||||
Price-to-Net-Current-Asset-Value | 2.89 | |||||
Price-to-Net-Cash | 2.96 | |||||
Earnings Yield (Greenblatt) % | -24.94 | |||||
FCF Yield % | -13.16 |